Skip to main content

Advertisement

Log in

Palliative Considerations Regarding Enteral Access in Surgical Patients

  • NUTRITION, METABOLISM, AND SURGERY (K.R. MILLER, SECTION EDITOR)
  • Published:
Current Surgery Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

With a focus on advanced-stage cancer patients, this review will highlight applications of nutrition support both as an adjunct therapy for a subset of conditions and as a key standard of practice in palliative care.

Recent Findings

Recent studies indicate the importance of early integration of palliative care into the treatment of patients with advanced cancer. Advances in the field of cancer-directed therapies have led to historically incurable cancers being treated more like chronic diseases. The type, method, and role of nutrition in the management of these patients are critical components of the treatment of advanced cancer patients.

Summary

Nutrition support for surgical, critically or terminally ill patients has undergone significant advances in the last decades. These patients are at an increased risk of malnutrition. Acute and chronic illness, trauma, inflammation stress-related catabolism, and drug-induced adverse effects may reduce appetite or increase nausea and vomiting in such patients. Proper surgical palliation for an incurable disease aims to incorporate the ethos of palliative care into an acute setting and this requires a multidisciplinary approach, primarily concentrating on improving patients’ quality of life. An important element of providing palliation to patients with late-stage cancer is to understand the role of nutrition. Methods to deliver nutrition include provision of either enteral nutrition, parenteral nutrition, or a combination of both. Enteral access is considered in patients who cannot ingest food normally but whose gastrointenstinal (GI) tract is adequate for digestion and absorbtion of required nutrients. Regardless of the type of advanced cancer, the overall objectives of palliative interventions must be clearly defined before proceeding and re-evaluated often, for all patients in whom enteral access is being considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Saluja SS, Kaur N, Shrivastava UK. Enteral nutrition in surgical patients. Surg Today. 2002;32(8):672–8.

    CAS  PubMed  Google Scholar 

  2. Rana SK, Bray J, Menzies-Gow N, Jameson J, James JJP, Frost P, Silk DB. Short term benefits of post-operative oral dietary supplements in surgical patients. Clin Nutr. 1992;11(6):337–44.

    CAS  PubMed  Google Scholar 

  3. ∙ Beattie AH, Prach AT, Baxter JP, Pennington CR. A randomised controlled trial evaluating the use of enteral nutritional supplements postoperatively in malnourished surgical patients. Gut 2000;46(6):813–8. Focusing generally on surgical patients, this paper suggests that postoperative nutritional supplementation improves nutritional status, QOL, and morbidity in these patients.

  4. Blum D, Stene GB, Solheim TS, Fayers P, Hjermstad MJ, Baracos VE, Fearon K, Strasser F, Kaasa S, Euro I. Validation of the consensus-definition for cancer cachexia and evaluation of a classification model:a study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol. 2014;25(8):1635–42.

    CAS  PubMed  Google Scholar 

  5. Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17105.

    PubMed  Google Scholar 

  6. ∙∙ Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hutterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Muhlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11–48. As an update to their published paper in 2006, these evidence-based guidelines were developed to translate current best evidence and expert opinion into recommendations for multi-disciplinary teams responsible for identification, prevention, and treatment of reversible elements of malnutrition in adult cancer patients.

  7. Isidro MF, Lima DS. Protein-calorie adequacy of enteral nutrition therapy in surgical patients. Rev Assoc Med Bras. 2012;58(5):580–6.

    PubMed  Google Scholar 

  8. Kang J, Park JS, Yoon DS, Kim WJ, Chung HY, Lee SM, Chang N. A study on the dietary intake and the nutritional status among the pancreatic cancer surgical patients. Clin Nutr Res. 2016;5(4):279–89.

    PubMed  PubMed Central  Google Scholar 

  9. Shi J, Wei L, Huang R, Liao L. Effect of combined parenteral and enteral nutrition versus enteral nutrition alone for critically ill patients: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97(41):e11874.

    Google Scholar 

  10. ∙ Mazaki T, Ebisawa K. Enteral versus parenteral nutrition after gastrointestinal surgery: a systematic review and meta-analysis of randomized controlled trials in the English literature. J Gastrointest Surg. 2008;12(4):739–55. This study recommends the use of EN over PN when possible and indicated.

  11. Ciambella CC, Beard RE, Miner TJ. Current role of palliative interventions in advanced pancreatic cancer. World J Gastrointest Surg. 2018;10(7):75–83.

    PubMed  PubMed Central  Google Scholar 

  12. Ichimaru S. Methods of enteral nutrition administration in critically ill patients: continuous, cyclic, intermittent, and bolus feeding. Nutr Clin Pract. 2018;33(6):790–5.

    CAS  PubMed  Google Scholar 

  13. Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, Dionne-Odom JN, Frost J, Dragnev KH, Hegel MT, Azuero A, Ahles TA. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the enable III randomized controlled trial. J Clin Oncol. 2015;33(13):1438–45.

    PubMed  PubMed Central  Google Scholar 

  14. Malhotra C, Xiang L, Ozdemir S, Kanesvaran R, Chan N, Finkelstein EA. A comparison of attitudes toward length and quality of life between community-dwelling older adults and patients with advanced cancer. Psychooncology. 2017;26(10):1611–7.

    PubMed  Google Scholar 

  15. Hamilton DW, Bins JE, McMeekin P, Pedersen A, Steen N, De Soyza A, Thomson R, Paleri V, Wilson JA. Quality compared to quantity of life in laryngeal cancer: a time trade-off study. Head Neck. 2016;38(Suppl 1):E631–E637637.

    PubMed  Google Scholar 

  16. ∙ Janah A, Gauthier LR, Morin L, Bousquet PJ, Le Bihan C, Tuppin P, Peretti-Watel P, Bendiane MK. Access to palliative care for cancer patients between diagnosis and death: a national cohort study. Clin Epidemiol. 2019;11: 443–455. This France based study warrants for optimizing access to early, standardized palliative care.

  17. ∙∙ Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, Firn JI, Paice JA, Peppercorn JM, Phillips T, Stovall EL, Zimmermann C, Smith TJ. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(1):96–112. A comprehensive study offering recommendations for integrating palliative care within oncology.

  18. Belanger E, Rodriguez C, Groleau D, Legare F, MacDonald ME, Marchand R. Patient participation in palliative care decisions: an ethnographic discourse analysis. Int J Qual Stud Health Well-Being. 2016;11:32438.

    PubMed  Google Scholar 

  19. ∙∙ Kaasa S, Loge JH, Aapro M, Albreht T, Anderson R, Bruera E, Brunelli C, Caraceni A, Cervantes A, Currow DC, Deliens L, Fallon M, Gomez-Batiste X, Grotmol KS, Hannon B, Haugen DF, Higginson IJ, Hjermstad MJ, Hui D, Jordan K, Kurita GP, Larkin PJ, Miccinesi G, Nauck F, Pribakovic R, Rodin G, Sjogren P, Stone P, Zimmermann C, Lundeby T. Integration of oncology and palliative care: a Lancet Oncology Commission. Lancet Oncol. 2018;19(11):e588–653. This paper emphasises upon the integration of oncology and palliative care focusing on two-modes of care, tumor-directed and host-directed approach. This paper has received several citations and positive commentary.

  20. Courteau C, Chaput G, Musgrave L, Khadoury A. Patients with advanced cancer: when, why, and how to refer to palliative care services. Curr Oncol. 2018;25(6):403–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Gartner J, Daun M, Wolf J, von Bergwelt-Baildon M, Hallek M. Early palliative care: pro, but please be precise! Oncol Res Treat. 2019;42(1–2):11–8.

    PubMed  Google Scholar 

  22. Hui D, Hannon BL, Zimmermann C, Bruera E. Improving patient and caregiver outcomes in oncology: team-based, timely, and targeted palliative care. CA Cancer J Clin. 2018;68(5):356–76.

    PubMed  PubMed Central  Google Scholar 

  23. Arends J. Struggling with nutrition in patients with advanced cancer: nutrition and nourishment-focusing on metabolism and supportive care. Ann Oncol. 2018;29(2):ii27–34.

    CAS  PubMed  Google Scholar 

  24. Woo SM, Song MK, Lee M, Joo J, Kim DH, Kim JH, Han SS, Park SJ, Kim TH, Lee WJ. Effect of early management on pain and depression in patients with pancreatobiliary cancer: a randomized clinical trial. Cancers (Basel). 2019;11(1):79.

    Google Scholar 

  25. Miller A, Schwaitzberg S. Surgical and endoscopic options for benign and malignant gastric outlet obstruction. Curr Surg Rep. 2014;2(4):48.

    Google Scholar 

  26. Thomay AA, Jaques DP, Miner TJ. Surgical palliation: getting back to our roots. Surg Clin N Am. 2009;89(1):27–41.

    PubMed  Google Scholar 

  27. Krouse RS, Nelson RA, Farrell BR, Grube B, Juarez G, Wagman LD, Chu DZ. Surgical palliation at a cancer center: incidence and outcomes. Arch Surg. 2001;136(7):773–8.

    CAS  PubMed  Google Scholar 

  28. ∙ Miner TJ, Jaques DP, Shriver CD. A prospective evaluation of patients undergoing surgery for the palliation of an advanced malignancy. Ann Surg Oncol. 2002;9(7):696–703. Study suggests that palliative procedures maybe beneficial for a subset of patients.

  29. Van Cleave JH, Fu MR, Bennett AV, Persky MS, Li Z, Jacobson A, Hu KS, Most A, Concert C, Kamberi M, Mojica J, Peyser A, Riccobene A, Tran A, Persky MJ, Savitski J, Liang E, Egleston BL. The development, usability, and reliability of the Electronic Patient Visit Assessment (ePVA) for head and neck cancer. Mhealth. 2019;5:21.

    PubMed  PubMed Central  Google Scholar 

  30. de Pinho NB, Martucci RB, Rodrigues VD, D'Almeida CA, Thuler LCS, Saunders C, Jager-Wittenaar H, Peres WAF. Malnutrition associated with nutrition impact symptoms and localization of the disease: results of a multicentric research on oncological nutrition. Clin Nutr. 2019;38(3):1274–9.

    PubMed  Google Scholar 

  31. Kristensen MB, Isenring E, Brown B. Nutrition and swallowing therapy strategies for patients with head and neck cancer. Nutrition. 2019;69:110548.

    PubMed  Google Scholar 

  32. Cocks H, Ah-See K, Capel M, Taylor P. Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(S2):S198–S207.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Peterson MK, Mohar I, Lam T, Cook TJ, Engel AM, Lynch H. Critical review of the evidence for a causal association between exposure to asbestos and esophageal cancer. Crit Rev Toxicol. 2019;49(7):597–613.

    CAS  PubMed  Google Scholar 

  34. Cools-Lartigue J, Spicer J, Ferri LE. Current status of management of malignant disease: current management of esophageal cancer. J Gastrointest Surg. 2015;19(5):964–72.

    PubMed  Google Scholar 

  35. ∙ Reim D, Friess H. Feeding challenges in patients with esophageal and gastroesophageal cancers. Gastrointest Tumors. 2016;2(4):166–77. Study identifies that (i) early nutritional interventions during multimodal/neoadjuvant treatment may be beneficial for weight loss reductionin (ii) palliative patients that insertion of self-expanding metal stents can reduce dysphagia and improve quality of life, but does not prolong overall survival.

  36. Tasleem SH, Inayat F, Ali NS, Sattar SBA, Munir A, Zafar F. Small bowel perforation secondary to esophageal stent migration: a comparative review of six cases. Cureus. 2018;10(10):e3455.

    PubMed  PubMed Central  Google Scholar 

  37. Lim ST, Choa RG, Lam KH, Wong J, Ong GB. Total parenteral nutrition versus gastrostomy in the preoperative preparation of patients with carcinoma of the oesophagus. Br J Surg. 1981;68(2):69–72.

    CAS  PubMed  Google Scholar 

  38. Yang CW, Lin HH, Hsieh TY, Chang WK. Palliative enteral feeding for patients with malignant esophageal obstruction: a retrospective study. BMC Palliat Care. 2015;14:58.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointest Endosc. 2016;84(1):18–28.

    PubMed  Google Scholar 

  40. Keranen I, Kylanpaa L, Udd M, Louhimo J, Lepisto A, Halttunen J, Kokkola A. Gastric outlet obstruction in gastric cancer: a comparison of three palliative methods. J Surg Oncol. 2013;108(8):537–41.

    PubMed  Google Scholar 

  41. Chang YR, Han DS, Kong SH, Lee HJ, Kim SH, Kim WH, Yang HK. The value of palliative gastrectomy in gastric cancer with distant metastasis. Ann Surg Oncol. 2012;19(4):1231–9.

    PubMed  Google Scholar 

  42. Blakely AM, McPhillips J, Miner TJ. Surgical palliation for malignant disease requiring locoregional control. Ann Palliat Med. 2015;4(2):48–53.

    PubMed  Google Scholar 

  43. Miner TJ, Jaques DP, Karpeh MS, Brennan MF. Defining palliative surgery in patients receiving noncurative resections for gastric cancer. J Am Coll Surg. 2004;198(6):1013–21.

    PubMed  Google Scholar 

  44. Fernandez-Moreno MC, Marti-Obiol R, Lopez F, Ortega J. Modified devine exclusion for unresectable distal gastric cancer in symptomatic patients. Case Rep Gastroenterol. 2017;11(1):9–16.

    PubMed  PubMed Central  Google Scholar 

  45. Kato H, Tsutsumi K, Okada H. Recent advancements in stent therapy in patients with malignant gastroduodenal outlet obstruction. Ann Transl Med. 2017;5(8):186.

    PubMed  PubMed Central  Google Scholar 

  46. van Halsema EE, Rauws EA, Fockens P, van Hooft JE. Self-expandable metal stents for malignant gastric outlet obstruction: a pooled analysis of prospective literature. World J Gastroenterol. 2015;21(43):12468–81.

    PubMed  PubMed Central  Google Scholar 

  47. Upchurch E, Ragusa M, Cirocchi R. Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction. Cochrane Database Syst Rev. 2018;5:CD012506.

    PubMed  Google Scholar 

  48. Potz BA, Miner TJ. Surgical palliation of gastric outlet obstruction in advanced malignancy. World J Gastrointest Surg. 2016;8(8):545–55.

    PubMed  PubMed Central  Google Scholar 

  49. Bulut E, Ciftci T, Akhan O, Akinci D. Palliation of malignant gastroduodenal obstruction: fluoroscopic metallic stent placement with different approaches. Diagn Interv Radiol. 2017;23(3):211–6.

    PubMed  PubMed Central  Google Scholar 

  50. Lopera JE, Brazzini A, Gonzales A, Castaneda-Zuniga WR. Gastroduodenal stent placement: current status. Radiographics. 2004;24(6):1561–73.

    PubMed  Google Scholar 

  51. Nagaraja V, Eslick GD, Cox MR. Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction-a systematic review and meta-analysis of randomized and non-randomized trials. J Gastrointest Oncol. 2014;5(2):92–8.

    PubMed  PubMed Central  Google Scholar 

  52. Bagni K, Chen IM, Johansen AZ, Dehlendorff C, Jensen BV, Hansen CP, Preus Hasselby J, Hollander NH, Nissen M, Bjerregaard JK, Pfeiffer P, Yilmaz MK, Rasmussen LS, Nielsen SE, Johansen JS. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer. Eur J Cancer Care. 2020. https://doi.org/10.1111/ecc.13219.

    Article  Google Scholar 

  53. Perinel J, Adham M. Palliative therapy in pancreatic cancer-palliative surgery. Transl Gastroenterol Hepatol. 2019;4:28.

    PubMed  PubMed Central  Google Scholar 

  54. Colibaseanu DT, Osagiede O, Spaulding AC, Frank RD, Merchea A, Mathis KL, Parker AS, Ailawadhi S. The determinants of palliative care use in patients with colorectal cancer: a national study. Am J Hosp Palliat Care. 2018;35(10):1295–303.

    PubMed  Google Scholar 

  55. van der Geest LG, Lam-Boer J, Koopman M, Verhoef C, Elferink MA, de Wilt JH. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis. 2015;32(5):457–65.

    PubMed  Google Scholar 

  56. Dixon MR, Stamos MJ. Strategies for palliative care in advanced colorectal cancer. Diges Surg. 2004;21(5–6):344–51.

    Google Scholar 

  57. Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765–29765.

    PubMed  PubMed Central  Google Scholar 

  58. Krouse RS. Malignant bowel obstruction. J Surg Oncol. 2019;120(1):74–7.

    PubMed  Google Scholar 

  59. Badgwell BD, Contreras C, Askew R, Krouse R, Feig B, Cormier JN. Radiographic and clinical factors associated with improved outcomes in advanced cancer patients with bowel obstruction. J Palliat Med. 2011;14(9):990–6.

    PubMed  Google Scholar 

  60. Shaw C, Bassett RL, Fox PS, Schmeler KM, Overman MJ, Wallace MJ, Gupta S, Tam A. Palliative venting gastrostomy in patients with malignant bowel obstruction and ascites. Ann Surg Oncol. 2013;20(2):497–505.

    PubMed  Google Scholar 

  61. Hall CC, Cook J, Maddocks M, Skipworth RJE, Fallon M, Laird BJ. Combined exercise and nutritional rehabilitation in outpatients with incurable cancer: a systematic review. Support Care Cancer. 2019;27(7):2371–84.

    PubMed  PubMed Central  Google Scholar 

  62. Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC, Tisdale MJ. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003;52(10):1479–86.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. ∙∙ Hebuterne X, Lemarie E, Michallet M, de Montreuil CB, Schneider SM, Goldwasser F. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN J Parenter Enteral Nutr. 2014;38(2):196–204. This research article identifies a highter prevalence of malnutrition in patients with cancer, suggesting a systematic screening process and treatment for malnutrition is imperative.

  64. Sandmael JA, Sand K, Bye A, Solheim TS, Oldervoll L, Helvik AS. Nutritional experiences in head and neck cancer patients. Eur J Cancer Care (Engl). 2019. https://doi.org/10.1111/ecc.13168.

    Article  Google Scholar 

  65. Miner TJ, Brennan MF, Jaques DP. A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer. Ann Surg. 2004;240(4):719–26.

    PubMed  PubMed Central  Google Scholar 

  66. Lembeck ME, Pameijer CR, Westcott AM. The role of intravenous fluids and enteral or parenteral nutrition in patients with life-limiting illness. Med Clin N Am. 2016;100(5):1131–41.

    PubMed  Google Scholar 

  67. Feldstain A, Lebel S, Chasen MR. The longitudinal course of depression symptomatology following a palliative rehabilitation program. Qual Life Res. 2017;26(7):1809–18.

    PubMed  Google Scholar 

  68. ∙ Cotogni P. Enteral versus parenteral nutrition in cancer patients: evidences and controversies. Ann Palliat Med. 2016;5(1): 42–9. This review suggests that EN and PN have to be considered equally effective in maintaining or improving nutritional status in cancer patients.

  69. ∙∙ Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G, van Bokhorst-de van der Schueren MA, von Meyenfeldt M, Zurcher G, Fietkau R, Aulbert E, Frick B, Holm M, Kneba M, Mestrom HJ, Zander A, Espen. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr. 2006;25(2):245–59. A mandate published 14 years ago, providing evidence-based recommendations for the use of oral nutrient supplements and tube feeding in cancer patients.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christopher M. Jones.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical collection on Nutrition, Metabolism, and Surgery.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Narayanan, S., Nagengast, A., Hussain, A. et al. Palliative Considerations Regarding Enteral Access in Surgical Patients. Curr Surg Rep 8, 4 (2020). https://doi.org/10.1007/s40137-020-00249-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s40137-020-00249-3

Keywords

Navigation